Literature DB >> 16537445

Cofactor-containing antibodies: crystal structure of the original yellow antibody.

Xueyong Zhu1, Paul Wentworth, Robert A Kyle, Richard A Lerner, Ian A Wilson.   

Abstract

Antibodies are generally thought to be a class of proteins that function without the use of cofactors. However, it is not widely appreciated that antibodies are believed to be the major carrier protein in human circulation for the important riboflavin cofactor that is involved in a host of biological phenomena. A further link between riboflavin and antibodies was discovered 30 years ago when a bright-yellow antibody, IgG(GAR), was purified from a patient with multiple myeloma who had turned yellow during the course of her disease. It was subsequently shown that the yellow color of this antibody was due to riboflavin binding. However, it was not known how and where riboflavin was bound to this antibody. We now report the crystal structure of this historically important IgG(GAR) Fab at 3.0-A resolution. The riboflavin is located in the antigen-combining site with its isoalloxazine ring stacked between the parallel aromatic moieties of TyrH33, PheH58, and TyrH100A. Together with additional hydrogen bonds, these interactions reveal the structural basis for high-affinity riboflavin binding. The ligand specificity of IgG(GAR) is compared with another riboflavin-binding antibody, IgG(DOT), which was purified from a second patient with multiple myeloma. The crystal structure of IgG(GAR) provides a starting point for attempts to understand the physiological relevance and chemical functions of cofactor-containing antibodies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537445      PMCID: PMC1450126          DOI: 10.1073/pnas.0600251103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Kabat Database and its applications: future directions.

Authors:  G Johnson; T T Wu
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  Unraveling the mysteries of gammadelta T cell recognition.

Authors:  I A Wilson; R L Stanfield
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

3.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

4.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

5.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

6.  Conformations of the third hypervariable region in the VH domain of immunoglobulins.

Authors:  V Morea; A Tramontano; M Rustici; C Chothia; A M Lesk
Journal:  J Mol Biol       Date:  1998-01-16       Impact factor: 5.469

7.  Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies.

Authors:  A C Martin; J M Thornton
Journal:  J Mol Biol       Date:  1996-11-15       Impact factor: 5.469

8.  The second riboflavin-binding myeloma IgG lambdaDOT. I. Biochemical and functional characterization.

Authors:  G Merlini; R Bruening; R A Kyle; E F Osserman
Journal:  Mol Immunol       Date:  1990-05       Impact factor: 4.407

9.  Further studies of the riboflavin-binding immunoglobulin IgGGar. Resolution into fractions of different riboflavin content and aspects of reassembly.

Authors:  M Y Chang; F K Friedman; S Beychok; J S Shyong; E F Osserman
Journal:  Biochemistry       Date:  1981-05-12       Impact factor: 3.162

10.  Myeloma with xanthoderma due to an IgG lambdamonoclonal anti-flavin antibody.

Authors:  M Farhangi; E F Osserman
Journal:  N Engl J Med       Date:  1976-01-22       Impact factor: 91.245

View more
  14 in total

1.  Robert Arthur Kyle, MD: a conversation with the editor.

Authors:  Robert Arthur Kyle; William Clifford Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-10

2.  Prevalence and gene characteristics of antibodies with cofactor-induced HIV-1 specificity.

Authors:  Maxime Lecerf; Tobias Scheel; Anastas D Pashov; Annaelle Jarossay; Delphine Ohayon; Cyril Planchais; Stephane Mesnage; Claudia Berek; Srinivas V Kaveri; Sébastien Lacroix-Desmazes; Jordan D Dimitrov
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

3.  Investigation of Color in a Fusion Protein Using Advanced Analytical Techniques: Delineating Contributions from Oxidation Products and Process Related Impurities.

Authors:  Hangtian Song; Jianlin Xu; Mi Jin; Chao Huang; Jacob Bongers; He Bai; Wei Wu; Richard Ludwig; Zhengjian Li; Li Tao; Tapan K Das
Journal:  Pharm Res       Date:  2015-12-10       Impact factor: 4.200

4.  Correlation analysis of riboflavin, RFT2 and Helicobater pylori in gastric carcinoma.

Authors:  Muattar Matnuri; Chao Zheng; Dildar Sidik; Ge Bai; Mamatjan Abdukerim; Aliye Abdukadier; Kilara Ahmat; Yue Ma; Maynur Eli
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Hydroxocobalamin association during cell culture results in pink therapeutic proteins.

Authors:  Kenneth M Prentice; Ronald Gillespie; Nathan Lewis; Kiyoshi Fujimori; Rebecca McCoy; Julia Bach; Lisa Connell-Crowley; Catherine M Eakin
Journal:  MAbs       Date:  2013-07-26       Impact factor: 5.857

6.  Antibody-catalyzed anaerobic destruction of methamphetamine.

Authors:  Yang Xu; Mark S Hixon; Noboru Yamamoto; Laura A McAllister; Anita D Wentworth; Paul Wentworth; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

7.  Recognition of riboflavin and the capsular polysaccharide of Haemophilus influenzae type b by antibodies generated to the haptenic epitope D-ribitol.

Authors:  G Ravi; Yeldur P Venkatesh
Journal:  Glycoconj J       Date:  2014-03-19       Impact factor: 2.916

Review 8.  Breaking the law: unconventional strategies for antibody diversification.

Authors:  Alexia Kanyavuz; Annaelle Marey-Jarossay; Sébastien Lacroix-Desmazes; Jordan D Dimitrov
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

Review 9.  The Different Colors of mAbs in Solution.

Authors:  Alexandre Ambrogelly
Journal:  Antibodies (Basel)       Date:  2021-05-24

10.  Riboflavin ameliorates cisplatin induced toxicities under photoillumination.

Authors:  Iftekhar Hassan; Sandesh Chibber; Aijaz A Khan; Imrana Naseem
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.